| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.23 | 6e-06 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |